FEMA GRAS status for Sweegen's sweet protein brazzein technology
Global sweetness and flavor innovator, Sweegen has announced that its highly sought-after sweet protein Ultratia™ brazzein technology received the Generally Recognized As Safe (GRAS) status from the Flavor and Extract Manufacturers Association (FEMA).
Our customers and the industry have eagerly anticipated our brazzein FEMA GRAS status. Now, we are excited to offer it as the star sweet protein in our Sweetensify Flavors Collection. We’re pleased to demonstrate our Ultratia brazzein in the newly launched Sweetensify Flavors Collection at the IFT First trade show in Chicago July 17-19, 2023.
Brands are encouraged to visit Sweegen’s food and beverage application team at IFT First, the Sweegen booth, located at the South Building — S1619 — IFT, for a sensory experience and learn how it can easily fit into their food and beverage products.
Sweegen is the first to attain FEMA GRAS status and to produce brazzein commercially globally. The designation is important because it allows manufacturers to use Sweegen’s Sweetensify Flavors confidently, including the novel sweet protein brazzein in their product formulations.
Brazzein's unique characteristics make it special, and its commercialization and scaling have been challenging until now. Brazzein is a rare sweet protein that originates from the fruit of the West African climbing plant, oubli. To produce brazzein sustainably, Sweegen uses a proprietary precision fermentation process, which creates clean high-purity ingredients.
This important milestone in food and beverage creation symbolizes Sweegen delivering on its promise to brands for opening doors to scalable state-of-the-art technology for creating better-for-everyone food and beverages. The FEMA GRAS status is a testament to the safety of brazzein as a flavor modifier that our customers can trust to explore new and exciting taste-modulating solutions.
Sweetensify Flavors for taste modulation improves and modulates a variety of taste attributes, which can help brands push the boundaries of healthier product innovation. Brazzein’s exceptional formulation qualities inspired Sweegen to launch Sweentisify Flavors in April 2023. It is the newest flavor tool starring its novel sweet protein Ultratia brazzein, which also features thaumatin II and other unique proteins.
Sweegen's product development teams have discovered remarkable synergies between Sweetensify Flavors and our Signature Stevia systems.
Sweet proteins like brazzein have an affinity for different taste receptors on the tongue, especially the receptor known as T1R3, which is associated with both umami and sweetness perception. Leveraging this unique attribute, Sweetensify Flavors will enable product developers to maintain the quality of characteristic flavors and sweetness while reducing the amount of sugar they use in products.
Sweegen’s Ultratia brazzein has received great feedback from our customers during the initial formulations phase and tastings. Now, the timing of the FEMA GRAS status perfectly coincides with the launch of Sweegen’s Sweetensify Flavors, which offers the best sensory experience in better-for-everyone products.
Sweegen recently attained FEMA GRAS status for thaumatin II, a sweet protein complementary to brazzein. With the addition of brazzein, Sweegen continues to expand its portfolio of safe and effective taste modulating flavors that can help food and beverage manufacturers meet the demand for healthier and delicious products to align with consumers’ holistic approaches to wellness.
Sweegen provides sweet-taste solutions for food and beverage manufacturers around the world.
We are on a mission to reduce sugar and artificial sweeteners in the global diet. Partnering with customers, we create delicious zero-sugar products that consumers love. With the best modern sweeteners in our portfolio, such as Bestevia® Rebs B, D, E, I, M, and N, and sweet proteins brazzein and thaumatin, along with our deep knowledge of flavor modulators and texturants, Sweegen delivers market-leading solutions that customers want, and consumers prefer. Well. Into the Future.
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1996. Sweegen’s actual results may differ from the estimates, assumptions, and other illustrative material contained herein, and consequently, a reader should not rely on these forward-looking statements as predictions of future events. These forward-looking statements include, without limitation, illustrative information regarding Sweegen’s bottom-up assumed market potential, assumed hit rate, and the resulting revenue based on these model inputs. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Industry, Market, and Other Data
In this press release, we rely on and refer to information and statistics regarding market participants in the sectors in which Sweegen competes and other data. We obtained this information and statistics from our own internal estimates and third-party sources, including reports by market research firms and company filings. We do not expressly refer to these sources. All of this information involves a number of assumptions and limitations, and the sources of such information cannot guarantee the accuracy or completeness of such information. The industry in which Sweegen operates is subject to a high degree of uncertainty and risk due to a variety of important factors, any of which could cause results to differ materially from those expressed in the estimates made by Sweegen or third parties.
Cautionary Statement Concerning Forward-Looking Statements
This press release contains forward-looking statements, including, among other statements, statements regarding the future prospects for Reb M stevia leaf sweetener, brazzein, and thaumatin. These statements are based on current expectations, but are subject to certain risks and uncertainties, many of which are difficult to predict and beyond Sweegen's control.
Relevant risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements and therefore should be carefully considered. Sweegen assumes no obligation to update any forward-looking statements as a result of new information or future events or developments.